Atlas Trials

Lidocaine Mucilage-ICG as an Optical Agent for Tumor Delineation During Breast-conserving Surgery

Clinical trial NCT04438577 · UNKNOWN

Trial details

NCT number
NCT04438577
Sponsor
Shantou Central Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-08-20
Primary completion
2021-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.